Managing osteoporosis with HMW PEG

Abstract

The present invention relates to the administration of compositions comprising polyethylene glycol, for improving the general gastrointestinal health of an animal increasing growth performance and treating osteopenia, osteoporosis and other bone disorders.

The invention claimed is: 
     
       1. A method for treating osteopenia or osteoporosis comprising orally administering to an animal in need thereof a therapeutically effective dose of a composition consisting essentially of a high molecular weight polyethylene glycol (HMW-PEG) having an average molecular weight of between 15,000 daltons and 20,000 daltons, wherein the HMW-PEG comprises at least two hydrocarbon chains attached to a hydrophobic core, wherein each hydrocarbon chain has an average molecular weight of at least 40 percent of the HMW-PEG compound, and wherein the hydrophobic core comprises a ring structure. 
     
     
       2. The method of  claim 1 , wherein the animal is selected from the group consisting of dog, cat, horse, sheep, goat, cow, pig, chicken, turkey and human. 
     
     
       3. The method of  claim 1 , wherein the effective dose is sufficient to increase osteogenesis. 
     
     
       4. The method of  claim 1 , wherein the effective dose is sufficient to reduce bone resorption. 
     
     
       5. The method of  claim 1 , wherein the effective dose is sufficient to increase osteogenesis and reduce bone resorption.